Nibec Co

Nibec Co EBITDA per Share

The EBITDA per Share of Nibec Co (138610.KQ) as of Nov 5, 2026 is 442.11 KRW. In the previous year, EBITDA per Share was -609.66 KRW — a change of -172.52% (higher).

EBITDA per Share

442.11KRW

YoY

-172.52%

Last updated:

EBITDA per Share of Nibec Co is 2025 442.11 KRW. EBITDA per Share of Nibec Co was 2024 -609.66 KRW. It decreases by -172.52% higher compared to the previous year.

The Nibec Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-426.63 KRW
Jan 1, 2019
-166.25 KRW
Jan 1, 2020
-419.56 KRW
Jan 1, 2021
-216.42 KRW
Jan 1, 2022
160.42 KRW
Jan 1, 2023
-274.44 KRW
Jan 1, 2024
-609.66 KRW
Jan 1, 2025
442.11 KRW
The Nibec Co EBITDA per Share history
YEAREBITDA per ShareYoY
442.11KRW-172.52%
-609.66KRW+122.14%
-274.44KRW-271.08%
160.42KRW-174.12%
-216.42KRW-48.42%
-419.56KRW+152.37%
-166.25KRW-61.03%
-426.63KRW+68.37%
-253.39KRW-26.79%
-346.12KRW-17.62%
-420.13KRW-38.15%
-679.26KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nibec Co Stock analysis

What does Nibec Co do? Nibec Co Ltd generates revenue through the sale of dental health products and regeneration biomaterials under its own brands. The dental health segment includes Blanc Tis for tooth whitening, SensBlok for sensitive teeth remedies, and Clinplant for dental conditioners. The regeneration biomaterials category features OCS-B, OCS-H, and OCS-Collagen for bone grafts, alongside bone regenerative powders, bone morphogenetic materials, and peptide bone powders. Additionally, the company sells cosmetics via the Skin Aropa brand. Domestic and overseas markets are the primary sales channels for all product lines. The company targets healthcare professionals and consumers seeking dental care solutions, with dental health products appealing to individuals managing oral hygiene needs. Regeneration biomaterials are directed at medical institutions requiring advanced bone healing solutions, while Skin Aropa cosmetics cater to personal care consumers. Nibec Co Ltd's product portfolio spans both B2B and B2C segments, with dental and biomaterials serving clinical and consumer markets. Nibec Co Ltd's revenue streams are derived from direct sales of its branded products. The dental health product line, including Blanc Tis, SensBlok, and Clinplant, serves both retail and professional markets. Regeneration biomaterials such as OCS-B, OCS-H, OCS-Collagen, and related products are sold to medical facilities for clinical use. Skin Aropa cosmetics are distributed to consumers through retail channels. All products are marketed under their respective brand names without third-party branding. Nibec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nibec Co stock

EBITDA per Share of Nibec Co is 442.11 KRW in 2025.

EBITDA per Share of Nibec Co changed from -609.66 KRW to 442.11 KRW, representing a -172.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Nibec Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Nibec Co

All Key Metrics — Nibec Co